Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

J Favier, L Amar, AP Gimenez-Roqueplo - Nature Reviews …, 2015 - nature.com
Paragangliomas and phaeochromocytomas are neuroendocrine tumours whose pathogenesis
and progression are very strongly influenced by genetics. A germline mutation in one of …

Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working …

JWM Lenders, MN Kerstens, L Amar… - Journal of …, 2020 - journals.lww.com
Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require
timely diagnosis because of their potentially serious cardiovascular and sometimes life-…

[HTML][HTML] International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

L Amar, K Pacak, O Steichen, SA Akker… - Nature Reviews …, 2021 - nature.com
Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry
a germline mutation in one of the succinate dehydrogenase (SDHx) genes (SDHA, SDHB…

[PDF][PDF] Genetic testing in pheochromocytoma or functional paraganglioma

L Amar, J Bertherat, E Baudin, C Ajzenberg… - Journal of Clinical …, 2005 - Citeseer
Purpose To assess the yield and the clinical value of systematic screening of susceptibility
genes for patients with pheochromocytoma (pheo) or functional paraganglioma (pgl).

[PDF][PDF] SDH mutations establish a hypermethylator phenotype in paraganglioma

…, P Benit, A Buffet, C Marcaillou, J Bertherat, L Amar… - Cancer cell, 2013 - cell.com
Paragangliomas are neuroendocrine tumors frequently associated with mutations in RET,
NF1, VHL, and succinate dehydrogenase (SDHx) genes. Methylome analysis of a large …

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an …

…, M Rottenkolber, C Adolf, F Satoh, L Amar… - The lancet Diabetes & …, 2017 - thelancet.com
Background Although unilateral primary aldosteronism is the most common surgically
correctable cause of hypertension, no standard criteria exist to classify surgical outcomes. We …

Integrated genomic characterization of adrenocortical carcinoma

…, E Baudin, F Tissier, B Dousset, L Groussin, L Amar… - Nature …, 2014 - nature.com
Adrenocortical carcinomas (ACCs) are aggressive cancers originating in the cortex of the
adrenal gland 1 . Despite overall poor prognosis, ACC outcome is heterogeneous 2 , 3 . We …

[PDF][PDF] Comprehensive molecular characterization of pheochromocytoma and paraganglioma

…, SL Asa, AS Tischler, R Akbani, A Ally, L Amar… - Cancer cell, 2017 - cell.com
We report a comprehensive molecular characterization of pheochromocytomas and
paragangliomas (PCCs/PGLs), a rare tumor type. Multi-platform integration revealed that PCCs/…

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

…, UD Lichtenauer, D Penton, VR Schack, L Amar… - Nature …, 2013 - nature.com
Primary aldosteronism is the most prevalent form of secondary hypertension. To explore
molecular mechanisms of autonomous aldosterone secretion, we performed exome sequencing …

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a …

…, T Méatchi, C Badoual, J Bertherat, L Amar… - The lancet …, 2009 - thelancet.com
Background Phaeochromocytomas and paragangliomas are neuro-endocrine tumours that
occur sporadically and in several hereditary tumour syndromes, including the …